期刊选题

1、投稿方式：在线投稿。

2、官网网址：

https://ccmp.zcmu.edu.cn/zjzyy/home

https://www.sciencedirect.com/journal/clinical-complementary-medicine-and-pharmacology

3、投稿系统：

https://www.editorialmanager.com/ccmp

4、出刊日期：季刊，逢季末月出版。

5、官网信息：不收取出版费。

2023年12月4日星期一

《临床传统医学和药理学（英文）》获批国内统一连续出版物号

【官网信息】

CCMP CCMP 2023-11-28 13:52 发表于浙江

近日，国家新闻出版署批复，学术期刊《临床传统医学和药理学（英文）》（Clinical Traditional Medicine and Pharmacology，曾用英文名：Clinical Complementary Medicine and Pharmacology，ISSN 2772-3712），获批国内统一连续出版物号CN 33-1427/R2，并获颁期刊出版许可证。

《临床传统医学和药理学（英文）》是浙江中医药大学主办，委托Elsevier在线出版的英文学术期刊。该刊定位于临床传统医学和药理学领域，以刊登传统医学临床循证研究和具有循证证据的药理学研究为核心内容。2021年入选中国科技期刊卓越行动计划高起点新刊项目。目前已被DOAJ、CNKI、Dimensions、Ulrich's Periodicals Directory、ScienceDirect、EBSCO Essentials、EuroPub等数据库正式收录。

此次期刊获批CN号将为国内外传统医学领域学者专家提供更广阔的交流平台，促进传统医学学科的国际交流与发展。

《临床传统医学和药理学（英文）》

（Clinical Traditional Medicine and Pharmacology）

征稿启事【官网信息】

作为传统医学领域的学术期刊，Clinical Traditional Medicine and Pharmacology旨在搭建一个学术交流平台，发表采用目前公认的研究方法和认知模式来研究复杂医疗体系的科学问题的学术论文。主要关注补充医学的基本系统理论、临床循证试验、民族治疗学、药理机制、药代动力学研究和毒理学的研究。CCMP特别注重以临床疗效为基础的，传统医学的分子基础和作用机制研究，还发表关于新的实验技术和模型应用的研究性论文。接收的文章类型主要包括：随机对照的临床研究、非随机临床试验、系统回顾、简评、综述、实验研究、临床经验总结、文献研究、专题评述等。

一. 期刊主题

本期刊的主题包括但不限于：

1. 机制研究：阐明补充医学和其他民族药理学的分子/细胞靶点、信号通路和作用机制，包括其药效学，药剂学和毒理学研究。

2. 临床研究：采用循证医学思维方式和方法设计和开展的临床多中心随机对照研究、临床经验总结、临床观察研究、非随机临床试验相关的临床论文、临床安全性评价，病症研究等。

3. 物质基础研究：药材中新化合物的分离鉴定；药用次生代谢产物(黄酮、生物碱、皂苷等)、大分子（多糖和蛋白质）、微量元素等的化学分析和质量控制研究；

4. 医学模型和方法：制备和应用新动物、细胞模型和实验方法进行传统医学研究。

5. 分子基础研究：补充医学理论和体系中的分子基础，包括中药炮制理论、药性理论和配伍理论研究等。

二.  约稿要求

1. 来稿采用英文书写，接收后尚需作者提供中文摘要。论文类型包括系统综述、评论、原创文章、新论、新闻、观点、研究短讯等。凡内容符合上述范围，且未公开发表的论文，均可投稿。

2. 详细文稿格式要求见投稿须知栏。论文统一为Word或PDF格式文档，A4纸版面，标题文字用2号，作者信息用4号，正文用5号，1.5倍行距。

3. 稿件需经编委会审稿专家审查，编辑部对接收的稿件有修改权，不愿改动者请来稿时说明。本刊不收取审稿费及版面费。

投稿链接：https://www.editorialmanager.com/ccmp/default.aspx

地址：浙江中医药大学滨文校区23506室CCMP编辑办公室

电子邮箱：ccmp2020@163.com

CCMP编辑办公室

2021年4月17日

《临床传统医学和药理学（英文）》

（Clinical Traditional Medicine and Pharmacology）

投稿须知【官网信息】

《Clinical Traditional Medicine and Pharmacology》（ISSN：2772-3712）是由浙江中医药大学主办，并委托国际出版集团Elsevier在线出版的综合性学术期刊。Clinical Traditional Medicine and Pharmacology旨在搭建一个学术交流平台，发表采用目前公认的研究方法和认知模式来研究复杂医疗体系的科学问题的学术论文。

《Clinical Traditional Medicine and Pharmacology》主要关注补充医学的基本系统理论、临床循证试验、民族治疗学、药理机制、药代动力学研究和毒理学的研究。《Clinical Traditional Medicine and Pharmacology》特别注重以临床疗效为基础的，传统医学的分子基础和作用机制研究，还发表关于新的实验技术和模型应用的研究性论文。接收的文章类型主要包括：随机对照的临床研究、非随机临床试验、系统回顾和Meta分析、简评、综述、实验研究、临床经验总结、文献研究、专题评述等。欢迎全国高等医药院校,医药卫生系统科研、医疗单位和海外的作者踊跃投稿。为了提高期刊质量，增强学术交流，结合本刊特点，请作者投稿时参考以下投稿须知。

1.注意事项

1.1总体要求 文稿力求新颖性、原创性、科学性，要求主题明确、数据可靠、内容准确、逻辑严谨、文字精炼。

1.2 投稿 请使用投稿系统：https://www.editorialmanager.com/ccmp/default.aspx进行投稿，按照提示和引导上传稿件和附件。

1.3作者可登录投稿系统查询稿件处理情况。若在3个月内未收到稿件取舍的通知, 系仍在审理中。欲另投他刊请先在投稿系统中完成撤稿, 切勿一稿多投。

1.4通讯作者 需提供完整、准确的联系方式，包括电子邮件、联系方式和完整的通讯地址。作者通过投稿系统投稿，必须上传以下附件：

*投稿信

*论文（可编辑）

*图文摘要（可编辑）

*表格（可编辑）

*数据（可编辑）

*作者声明（所有作者签名）

补充材料（非必要）

数据摘要（非必要）

1.5稿件正文中必须包含以下信息：

*题目

*摘要

*关键词

*作者

*论文主体，包括Introduction, Materials and Methods (including Ethics Approval and Consent to Participate, Human and Animal Rights), Results, Discussion, Conclusion等

*致谢（Acknowledgements）或基金信息（Fundings）

*作者贡献声明（Author contributions）

*Compliance with ethical standards (Conflict of Interest、ethical approval)

1.6稿件需经编委会、审稿专家审查，编辑部对接收的稿件有修改权，不愿改动者请来稿时说明。本刊暂不收取审稿费及版面费。

2.撰稿要求

2.1标题 标题应当简洁明了，通常适用于信息检索系统查询，尽可能避免直接使用缩写和公式。

2.2作者姓名和所属单位 在作者姓名下方标注联系地址（可表明贡献）。在作者姓名后和相应地址前用小写字母标明从属关系。提供每个附属机构的完整邮政地址，包括国家名称和邮件地址（如果有的话）。

2.3通讯作者 在审稿和出版阶段，负责联系与对接的作者信息。请确保提供最新的邮件地址和联系方式。

2.4摘要 简明扼要、实事求是。摘要应包括以下几个方面：

背景：用一两句话总结您的研究的科学知识体系，以及这些知识是如何帮助您的研究的。

假设/目的:陈述研究中试图证明或否定的理论或假设。

研究设计：确定研究的总体设计。

方法：简要总结您在调查中使用的方法。

结果：报告最重要的研究结果。

结论：陈述问题或假设的结论。总结可以研究中得出的最重要的结论。

图形摘要：在投稿系统中，图形摘要应作为单独的文件提交。图像大小：请提供最小531×1328像素（高×宽）或更高比例的图像。图像的可读性应为5×13 cm，常规屏幕分辨率为96 dpi。首选文件类型：TIFF、EPS、PDF或MS Office文件。作者可以利用Elsevier的插图服务，以确保其图像符合要求。

2.5关键词  每篇文章需有3～8个关键词。使用美式拼写，避免使用一般和复数术语以及多个概念（例如，避免使用“and”、“of”）。缩略语：只有在这个领域里明确规定的缩略语可以使用。

2.6正文 论文统一为Word或PDF格式文档，A4纸版面，标题文字用2号，作者信息用4号，正文用5号，1.5倍行距。

2.7致谢 列于正文之后，参考文献之前。在此可列出研究过程中提供帮助的个人(例如，提供语言帮助、写作帮助或其他某项工作的辅助等)。

2.8单位 遵循国际公认的规则和惯例：采用国际单位制(SI)。如果使用其他单位，请在SI中给出相应的单位。

2.9彩色图稿

请确保图稿文件的格式可用(TIFF(或JPEG)、EPS(或PDF)或MS Office文件)，并且具有正确的分辨率。如果您提交了可用的彩色图稿文件，Elsevier将免费确保这些图稿文件以彩色形式出现在网上(例如，科学指导和其他网站)。

2.10参考文献

作者引用他人已发表的文、图、表或数据等, 需要在引用时列出参考文献以注明出处。

文字引用格式：

1. 单一作者：作者姓名（无首字母缩写，除非有歧义）和出版年份；

2. 两位作者：两位作者的姓名和出版年份；

3. 三位或更多作者：第一位作者的名字，后跟“ et al”和出版年份。引用可以直接（或带括号）进行。

清单格式：作者应仔细核对所引参考文献, 以保证各项内容准确无误。参考文献应首先按字母顺序排列，然后在必要时按时间顺序进一步排序。同一作者在同一年的多个参考文献在出版年份之后必须用字母“ a”，“ b”，“ c”等标识。

注：投稿系统：https://www.editorialmanager.com/ccmp/default.aspx

《临床传统医学和药理学（英文）》

（Clinical Traditional Medicine and Pharmacology）

作者须知【官网信息】

Guide for Authors

Aims and scope

Clinical Traditional Medicine and Pharmacology is an open access, quarterly, international, complimentary and integrative medicine journal. Clinical Traditional Medicine and Pharmacology considers articles on various types of therapeutic techniques and methodologies of complementary medicine, including herbal therapy and physical therapy, which were used for treating diseases and keeping healthy.

Scope

Clinical Traditional Medicine and Pharmacology favors herbal medicinal products with evidence-based therapeutic uses. This journal includes a wide range of fields to create a platform for explaining the complex medical system by current research and rhetorical cognitive modes. It primarily focuses on publishing investigations on the basic system theory, evidence-based clinical trial, special ethnic therapeutics, pharmacological mechanisms, pharmacokinetics research and toxicological research of complementary medicine.

Clinical Traditional Medicine and Pharmacology pays special attention to the researches on molecular bases and action mechanism of complementary medicine to evaluate its clinical efficacy. It also accepts articles on new experimental techniques and models for complimentary medicine research.

Topics included - but not restricted to - are:

Mechanistic studies: elucidate molecular/cellular targets, signaling pathways and mechanisms of action for the complimentary medicines and other ethnic medicines, including their pharmacodynamics, pharmaceutics and toxicological research.

Clinical research: disease and syndrome, the safety of TCM and other ethnic medicines in clinical, curative effect evaluation, evidence-based and system evaluation;

Material basis researches: the isolation and identification of new compounds from medicinal herbs; the chemical analysis and quality control research of medicinal secondary metabolites (flavones, alkaloids, saponins, etc), macromolecules (polysaccharides and proteins), trace elements and so on;

Medical models and methods: preparation and application of new animal and cell models and experimental methods for complimentary medicine research.

Molecular basis researches: the molecular basis of complimentary medical theories and concepts, including theories of processing Chinese materia medica, theories of medicine property and compatibility.

Clinical Traditional Medicine and Pharmacology considers the following article types: articles on randomized controlled trials, non-randomized trials, systematic review and meta-analyses, short communication, perspectives, original articles, clinical experiences, literature research, opinion, etc. The journal covers the following sections:

Invited opinions

Systematic reviews

Clinical research

Pharmacological research

Standardization and quality control

Biotechnology and plant biochemistry

Methodology and technology for complementary medicine research

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

Ethics in publishing

Please see our information on Ethics in publishing.

Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Preprints

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

……

更多详情：

https://www.elsevier.com/journals/clinical-complementary-medicine-and-pharmacology/2772-3712/guide-for-authors